$0.50
+0.01 (+2.00%)
Open$0.49
Previous Close$0.49
Day High$0.52
Day Low$0.48
52W High$3.27
52W Low$0.43
Volume—
Avg Volume78.8K
Market Cap8.23M
P/E Ratio—
EPS$-2.11
SectorPharmaceuticals
Analyst Ratings
Strong Sell
7 analysts
Price Target
+4,349.8% upside
Current
$0.50
$0.50
Target
$22.24
$22.24
$15.33
$22.24 avg
$34.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.59M | 4.81M | 4.77M |
| Net Income | 18.39M | 633.7K | 796.1K |
| Profit Margin | 328.7% | 13.2% | 16.7% |
| EBITDA | -35,834,521 | 1.15M | 1.15M |
| Free Cash Flow | — | 870.8K | 772.5K |
| Rev Growth | +131.1% | +22.7% | +21.0% |
| Debt/Equity | — | 0.81 | 0.64 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |